Equity Overview
Price & Market Data
Price: $1.47
Daily Change: -$0.08 / 5.44%
Range: $1.45 - $1.57
Market Cap: $5,490,284
Volume: 166,740
Performance Metrics
1 Week: 20.80%
1 Month: -29.11%
3 Months: -47.39%
6 Months: -51.91%
1 Year: -93.76%
YTD: -49.67%
Company Details
Employees: 52
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.